Long Acting Injections and Implants

Part of the series Advances in Delivery Science and Technology pp 475-503


In Vitro Drug Release Testing and In Vivo/In Vitro Correlation for Long Acting Implants and Injections

  • Michail KastelloriziosAffiliated withDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut
  • , Diane J. BurgessAffiliated withDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut Email author 

* Final gross prices may vary according to local VAT.

Get Access


An advantage of long acting implants and injections is their ability to maintain a relatively constant drug concentration at the site of interest. In vitro drug release testing, particularly where an in vivo/in vitro relationship has been established, can help in ensuring in vivo performance. There are various in vitro release testing methods, which are chosen, based on availability, dosage form specifications and drug properties. These are categorized into three groups: sample and separate, flow-through and dialysis. Although there are currently no standard methods for in vitro release testing of controlled release parenterals, standard dissolution apparatus specified by the United States Pharmacopeia have been adapted in some cases and the development of compendial monographs is anticipated. An in vivo/in vitro correlation can predict the bioavailability characteristics of a product based on release in vitro.